As the age of the world population rises, there is a concordant rise in age-associated diseases such as cancer, cardiovascular disease, and neurodegeneration. Understanding the aging process at the molecular level may aid development of preventative treatments for these diseases, as targeting lifespan-modulating pathways can be protective in models of age-onset diseases. However, lifespan-modulating pathways have wide ranging cellular effects, beyond delaying aging. To advance our understanding of genetic pathways contributing to longevity, and identify novel genetic targets to test in models of neurodegenerative disease, we identified "common" genes similarly modulated in a variety of long-lived genetic mutants. We performed RNA sequencing on nine long-lived genetic mutants representing six different lifespan-modulating pathways: insulin-IGF1 signaling (
daf-2), dietary restriction (
eat-2), germline deficiency (
glp-1), reduced mechanosensation (
osm-5), reduced translation (
ife-2), elevated mitochondrial reactive oxygen species (
sod-2), and weak mitochondrial impairment (
nuo-6,
isp-1,
clk-1). There is a significant overlap in differentially expressed genes between almost all pairs of long-lived mutants. Thus, diverse lifespan-modulating pathways converge onto overlapping genetic targets. The genes upregulated by the lifespan-modulating pathways fall primarily into two disparate groups: genes upregulated in
eat-2,
osm-5, and
ife-2 worms, and genes upregulated in
daf-2,
sod-2,
isp-1, and
nuo-6 worms. The two gene groups are enriched for different tissue expression and different molecular pathways, further supporting that these genes extend lifespan through distinct means. To identify "common" genes potentially shared across these groups, we selected for genes similarly modulated in at least six of the nine mutants. We identified 196 "common" upregulated genes enriched for genes involved in immunity and metabolism, and 62 "common" downregulated genes enriched for genes associated with translation initiation. We will determine if the overarching common genes are required for enhanced longevity and then examine if the group-specific genes are required for longevity in their respective mutants. Developing a clearer understanding of the specific genes and pathways which directly modulate lifespan will advance our understanding of the aging process, and help to develop preventative treatments for our aging population.